Tags

Type your tag names separated by a space and hit enter

[Management of anti-N-methyl-D-aspartate receptor encephalitis in children].
Zhongguo Dang Dai Er Ke Za Zhi. 2014 Jun; 16(6):584-8.ZD

Abstract

Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a new category of severe, potentially treatable autoimmune encephalitis and can appear in patients of all ages, but more frequently in children. It is a highly characteristic syndrome evolving in five stages: the prodromal phase (viral infection-like symptoms), psychotic phase, unresponsive phase, hyperkinetic phase, and gradual recovery phase. The treatment for this disorder includes first-line immunotherapy (steroids, intravenous immunoglobulin, plasmapheresis), second-line immunotherapy (rituximab, cyclophosphamide), and tumor removal. Hereby the progresses, selections and shortcomings of the treatment protocols for this disease are introduced.

Authors+Show Affiliations

Department of Pediatric Neurology, Jiangxi Children's Hospital, Nanchang 330006, China. zhongjm@163.com.

Pub Type(s)

English Abstract
Journal Article
Review

Language

chi

PubMed ID

24927432

Citation

Zhong, Jian-Min. "[Management of anti-N-methyl-D-aspartate Receptor Encephalitis in Children]." Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics, vol. 16, no. 6, 2014, pp. 584-8.
Zhong JM. [Management of anti-N-methyl-D-aspartate receptor encephalitis in children]. Zhongguo Dang Dai Er Ke Za Zhi. 2014;16(6):584-8.
Zhong, J. M. (2014). [Management of anti-N-methyl-D-aspartate receptor encephalitis in children]. Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics, 16(6), 584-8.
Zhong JM. [Management of anti-N-methyl-D-aspartate Receptor Encephalitis in Children]. Zhongguo Dang Dai Er Ke Za Zhi. 2014;16(6):584-8. PubMed PMID: 24927432.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Management of anti-N-methyl-D-aspartate receptor encephalitis in children]. A1 - Zhong,Jian-Min, PY - 2014/6/14/entrez PY - 2014/6/14/pubmed PY - 2014/10/17/medline SP - 584 EP - 8 JF - Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics JO - Zhongguo Dang Dai Er Ke Za Zhi VL - 16 IS - 6 N2 - Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a new category of severe, potentially treatable autoimmune encephalitis and can appear in patients of all ages, but more frequently in children. It is a highly characteristic syndrome evolving in five stages: the prodromal phase (viral infection-like symptoms), psychotic phase, unresponsive phase, hyperkinetic phase, and gradual recovery phase. The treatment for this disorder includes first-line immunotherapy (steroids, intravenous immunoglobulin, plasmapheresis), second-line immunotherapy (rituximab, cyclophosphamide), and tumor removal. Hereby the progresses, selections and shortcomings of the treatment protocols for this disease are introduced. SN - 1008-8830 UR - https://www.unboundmedicine.com/medline/citation/24927432/[Management_of_anti_N_methyl_D_aspartate_receptor_encephalitis_in_children]_ L2 - http://www.zgddek.com/EN/abstract/abstract13381.shtml DB - PRIME DP - Unbound Medicine ER -